Skip to main content

Table 2 Dose distribution for ten most frequently used antipsychotics during stable-dose period among case and control cohorts

From: Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesia

Drug Case (N, %) Case Stable Dose (mg), Mean ± SD Control (N, %) Control Stable Dose (mg), Mean ± SD
Risperidone 4564 (23.3) 7 ± 7 4135 (21.1) 5 ± 6
Quetiapine 3871 (19.8) 463 ± 278 3226 (16.5) 331 ± 254
Olanzapine 2558 (13.1) 22 ± 13 2422 (12.4) 17 ± 12
Aripiprazole 1838 (9.4) 29 ± 47 2712 (13.9) 22 ± 38
Paliperidone 1180 (6.0) 70 ± 68 1704 (8.7) 56 ± 63
Haloperidol 1472 (7.5) 31 ± 30 1396 (7.1) 22 ± 19
Ziprasidone 1185 (6.1) 147 ± 61 1026 (5.2) 125 ± 55
Clozapine 1251 (6.4) 407 ± 180 683 (3.5) 405 ± 190
Lurasidone 467 (2.4) 93 ± 42 820 (4.2) 68 ± 35
Fluphenazine 301 (1.5) 20 ± 13 277 (1.4) 15 ± 11
  1. SD standard deviation